vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Mayville Engineering Company, Inc. (MEC). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $134.3M, roughly 1.3× Mayville Engineering Company, Inc.). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -3.2%, a 2.5% gap on every dollar of revenue. On growth, Mayville Engineering Company, Inc. posted the faster year-over-year revenue change (10.7% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $10.2M). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs -8.8%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Mayville Engineering Company, Inc. is a U.S.-headquartered leading manufacturer of metal components, fabricated assemblies, and custom engineered solutions. It serves OEM clients across agriculture, construction, transportation, defense, and power sports markets, offering end-to-end services from prototyping to high-volume production for North America.
AVNS vs MEC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $134.3M |
| Net Profit | $-1.3M | $-4.4M |
| Gross Margin | 47.5% | 6.8% |
| Operating Margin | 1.4% | -4.1% |
| Net Margin | -0.7% | -3.2% |
| Revenue YoY | 0.7% | 10.7% |
| Net Profit YoY | 99.7% | -127.3% |
| EPS (diluted) | $-0.02 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $134.3M | ||
| Q3 25 | $177.8M | $144.3M | ||
| Q2 25 | $175.0M | $132.3M | ||
| Q1 25 | $167.5M | $135.6M | ||
| Q4 24 | $179.6M | $121.3M | ||
| Q3 24 | $170.4M | $135.4M | ||
| Q2 24 | $171.7M | $163.6M | ||
| Q1 24 | $166.1M | $161.3M |
| Q4 25 | $-1.3M | $-4.4M | ||
| Q3 25 | $-1.4M | $-2.7M | ||
| Q2 25 | $-76.8M | $-1.1M | ||
| Q1 25 | $6.6M | $20.0K | ||
| Q4 24 | $-397.3M | $16.0M | ||
| Q3 24 | $4.3M | $3.0M | ||
| Q2 24 | $1.8M | $3.8M | ||
| Q1 24 | $-900.0K | $3.2M |
| Q4 25 | 47.5% | 6.8% | ||
| Q3 25 | 48.4% | 11.0% | ||
| Q2 25 | 52.6% | 10.3% | ||
| Q1 25 | 53.6% | 11.3% | ||
| Q4 24 | 54.6% | 8.9% | ||
| Q3 24 | 54.5% | 12.6% | ||
| Q2 24 | 55.7% | 13.6% | ||
| Q1 24 | 57.1% | 13.0% |
| Q4 25 | 1.4% | -4.1% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | -42.6% | 0.1% | ||
| Q1 25 | 6.1% | 1.2% | ||
| Q4 24 | -233.0% | 19.0% | ||
| Q3 24 | 7.0% | 4.2% | ||
| Q2 24 | 3.7% | 5.0% | ||
| Q1 24 | 2.4% | 4.7% |
| Q4 25 | -0.7% | -3.2% | ||
| Q3 25 | -0.8% | -1.9% | ||
| Q2 25 | -43.9% | -0.8% | ||
| Q1 25 | 3.9% | 0.0% | ||
| Q4 24 | -221.2% | 13.2% | ||
| Q3 24 | 2.5% | 2.2% | ||
| Q2 24 | 1.0% | 2.3% | ||
| Q1 24 | -0.5% | 2.0% |
| Q4 25 | $-0.02 | $-0.22 | ||
| Q3 25 | $-0.03 | $-0.13 | ||
| Q2 25 | $-1.66 | $-0.05 | ||
| Q1 25 | $0.14 | $0.00 | ||
| Q4 24 | $-8.64 | $0.76 | ||
| Q3 24 | $0.09 | $0.14 | ||
| Q2 24 | $0.04 | $0.18 | ||
| Q1 24 | $-0.02 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $1.5M |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $240.7M |
| Total Assets | $1.1B | $563.6M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $1.5M | ||
| Q3 25 | $70.5M | $1.2M | ||
| Q2 25 | $90.3M | $206.0K | ||
| Q1 25 | $97.0M | $183.0K | ||
| Q4 24 | $107.7M | $206.0K | ||
| Q3 24 | $89.0M | $178.0K | ||
| Q2 24 | $92.2M | $314.0K | ||
| Q1 24 | $75.8M | $314.0K |
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $240.7M | ||
| Q3 25 | $778.0M | $244.8M | ||
| Q2 25 | $776.3M | $246.8M | ||
| Q1 25 | $839.4M | $250.0M | ||
| Q4 24 | $828.5M | $251.8M | ||
| Q3 24 | $1.2B | $238.4M | ||
| Q2 24 | $1.2B | $238.1M | ||
| Q1 24 | $1.2B | $234.0M |
| Q4 25 | $1.1B | $563.6M | ||
| Q3 25 | $1.1B | $585.6M | ||
| Q2 25 | $1.0B | $433.7M | ||
| Q1 25 | $1.1B | $447.7M | ||
| Q4 24 | $1.2B | $445.6M | ||
| Q3 24 | $1.7B | $466.0M | ||
| Q2 24 | $1.7B | $488.2M | ||
| Q1 24 | $1.7B | $499.9M |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $13.4M |
| Free Cash FlowOCF − Capex | $21.3M | $10.2M |
| FCF MarginFCF / Revenue | 11.8% | 7.6% |
| Capex IntensityCapex / Revenue | 3.8% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $26.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $13.4M | ||
| Q3 25 | $14.0M | $1.9M | ||
| Q2 25 | $6.8M | $15.0M | ||
| Q1 25 | $25.7M | $8.3M | ||
| Q4 24 | $57.9M | $38.0M | ||
| Q3 24 | $23.0M | $17.9M | ||
| Q2 24 | $27.8M | $23.3M | ||
| Q1 24 | $-8.0M | $10.6M |
| Q4 25 | $21.3M | $10.2M | ||
| Q3 25 | $7.0M | $-1.1M | ||
| Q2 25 | $-4.2M | $12.5M | ||
| Q1 25 | $19.0M | $5.4M | ||
| Q4 24 | $53.1M | $35.6M | ||
| Q3 24 | $20.0M | $15.1M | ||
| Q2 24 | $21.9M | $19.2M | ||
| Q1 24 | $-12.1M | $7.8M |
| Q4 25 | 11.8% | 7.6% | ||
| Q3 25 | 3.9% | -0.8% | ||
| Q2 25 | -2.4% | 9.5% | ||
| Q1 25 | 11.3% | 4.0% | ||
| Q4 24 | 29.6% | 29.4% | ||
| Q3 24 | 11.7% | 11.1% | ||
| Q2 24 | 12.8% | 11.7% | ||
| Q1 24 | -7.3% | 4.9% |
| Q4 25 | 3.8% | 2.4% | ||
| Q3 25 | 3.9% | 2.1% | ||
| Q2 25 | 6.3% | 1.8% | ||
| Q1 25 | 4.0% | 2.2% | ||
| Q4 24 | 2.7% | 1.9% | ||
| Q3 24 | 1.8% | 2.1% | ||
| Q2 24 | 3.4% | 2.5% | ||
| Q1 24 | 2.5% | 1.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | 416.65× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | 5.35× | 6.03× | ||
| Q2 24 | 15.44× | 6.15× | ||
| Q1 24 | — | 3.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
MEC
| Fabrication | $72.2M | 54% |
| Construction And Access | $19.2M | 14% |
| Tubes | $16.2M | 12% |
| Other Market | $11.9M | 9% |
| Agriculture | $7.7M | 6% |
| Military | $6.7M | 5% |
| Outdoor Sports | $1.7M | 1% |
